Do you or someone you care about have MS? MS PathwaysSM is the source for personalized B.E.T.A.SM Nurse support for BETASERON patients and those considering BETASERON therapy. Take advantage of the many helpful tools offered by MS PathwaysSM including informative Webcasts to help you make the most of living with MS.
Get a printable doctor-patient discussion guide to help prepare you for speaking with your healthcare professional about choosing a disease-modifying therapy.
Considering BETASERON
Not a moment to lose—every moment BETASERON is delayed is a moment you may not get back.1
Whether you're newly diagnosed, have had a first MS event, or have been living with a relapsing form of MS, and you are uncertain about how well your current therapy is working and considering a change of treatment—you can do something about it by learning more about BETASERON®. Consider talking to your healthcare professional about starting immediate treatment now. Remember, it's not a moment too soon.
What do the experts say about high-dose, high-frequency interferon beta?
MS experts recently stated that higher doses of interferon beta taken more often appear to be more effective than lower doses taken less often. Because BETASERON is the only high-dose interferon beta FDA-approved to be taken every other day, it is the most frequently dosed high-dose interferon beta therapy available. Remember—every moment BETASERON is delayed is a moment you may not get back.1
Treating with BETASERON at the first sign of MS may slow disease progression.
Recent studies have shown that long-term treatment with BETASERON at the first event may lower the risk of a second MS attack by 50%. Learn more
Reference:
BETASERON® (Interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
Important Safety Information
The most commonly reported adverse reactions are lymphopenia, injection-site reaction, asthenia, flu-like symptom complex, headache and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms. BETASERON should be used with caution in patients with depression. Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information.
